Erin Stockwell, NP
Nurse Practitioner · Chattanooga, TNNPI 1467838599
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Medtronic at 34.5% of the total. 2025 is the largest year on record at $6,057, 8.9 times the $682 reported in 2021. Among nurse practitioner clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 297 payments — averaging $50.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Boston Scientific$3K
- Saluda Medical Americas, Inc.$3K
- Vertos Medical, Inc.$1K
- Nalu Medical, Inc.$707
- Abbott$690
- plus $2K from 25 others
What the payments were for
- Consulting fees$9196%
- Travel & lodging$7,01346%
- Food & beverage$7,10547%
- Education$540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 64 | $5,203 |
| Boston Scientific | 59 | $3,309 |
| Saluda Medical Americas, Inc. | 35 | $2,517 |
| Vertos Medical, Inc. | 10 | $1,015 |
| Nalu Medical, Inc. | 9 | $707 |
| Abbott | 18 | $690 |
| Collegium Pharmaceutical, Inc. | 20 | $261 |
| Scilex Pharmaceuticals Inc. | 17 | $260 |
| AbbVie(2 entities) | 11 | $197 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $121 |
| Relievant Medsystems, Inc. | 3 | $72 |
| Arbor Pharmaceuticals, Inc. | 4 | $65 |
| Azurity Pharmaceuticals, Inc. | 3 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $58 |
| GRT US Holding, Inc. | 4 | $58 |
| Pacira Therapeutics, Inc. | 3 | $58 |
| Tersera Therapeutics LLC | 4 | $56 |
| Avanos Medical | 1 | $52 |
| Pfizer | 3 | $48 |
| Almatica Pharma LLC | 3 | $44 |
| Hikma Pharmaceuticals USA | 3 | $42 |
| Redhill Biopharma Inc. | 2 | $33 |
| MML US, Inc. | 2 | $27 |
| Fidia Pharma USA Inc. | 1 | $27 |
| Amgen | 2 | $25 |
| Protega Pharmaceutials Inc | 1 | $19 |
| Nevro Corp. | 1 | $19 |
| Biotronik NRO, Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Stimwave Technologies Incorporated | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$2,421
- Evoke$1,966
- WaveWriter Alpha Prime 16$1,374
- SYNCHROMEDII$1,227
- mild Device Kit$919
- GENERAL - THERAPIES$709
- Nalu Neurostimulation System$332
- ETERNA$321
- INCEPTIV$218
- PROCLAIM$120
How this compares
$15,090 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 41 | $59,657 |
| BelbucaBuprenorphine Hcl | 70 | $48,182 |
| Buprenorphine | 120 | $33,184 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,168 | $31,991 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 896 | $26,066 |
| ZtlidoLidocaine | 47 | $21,972 |
| Xtampza ErOxycodone Myristate | 40 | $20,709 |
| Aimovig AutoinjectorErenumab-Aooe | 20 | $20,044 |
| MovantikNaloxegol Oxalate | 41 | $16,674 |
| Lidocaine | 129 | $14,408 |
| LinzessLinaclotide | 21 | $11,534 |
| QuliptaAtogepant | 11 | $11,301 |
| NucyntaTapentadol Hcl | 11 | $9,085 |
| Gabapentin | 818 | $8,766 |
| Oxycodone Hcl | 382 | $7,882 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta | $261 | $77,976121 claims |
| PfizerNurtec Odt | $48 | $59,65741 claims |
| Hikma Pharmaceuticals USABuprenorphine | $42 | $33,184120 claims |
| AbbVieLinzess, Qulipta | $197 | $22,83532 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $260 | $21,97247 claims |
| Redhill Biopharma Inc.Movantik | $33 | $16,67441 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Chattanooga
- Cynthia WilsonChattanooga$62K
- Honor HightshueChattanooga$45K
- Amy OttmanChattanooga$32K
- Philip AndrewsChattanooga$18K
- Amberly EllisChattanooga$17K
- Teresa DeeseChattanooga$13K
- Jay PassmoreChattanooga$13K
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.